Core AI Launches New AI-Powered Digital Marketing Business to Accelerate Global Growth

(NASDAQ:CHAI), Miami, Nov. 21, 2025 (GLOBE NEWSWIRE) — Core AI Holdings, Inc. (Nasdaq: CHAI) (“Core AI” or the “Company“), an artificial intelligence infrastructure company building transformative and scalable offerings across multiple verticals, today announced the formation of Core Digital, a new wholly-owned subsidiary created to spearhead the Company's entry into the fast-growing digital marketing sector. […]

Bitget Teams Up with Ampersan to Accelerate Institutional Liquidity in the UEX Era

VICTORIA, Seychelles, Nov. 21, 2025 (GLOBE NEWSWIRE) — Bitget, the world's largest Universal Exchange (UEX), today announced a strategic collaboration with Ampersan, an institutional liquidity provider serving both centralized and decentralized markets. The collaboration strengthens Bitget's institutional offering with deeper liquidity coverage across spot, futures, and options markets, creating new channels for professional capital to

Bitget Teams Up with Ampersan to Accelerate Institutional Liquidity in the UEX Era

Bitget Teams Up with Ampersan to Accelerate Institutional Liquidity in the UEX Era GlobeNewswire November 21, 2025 VICTORIA, Seychelles, Nov. 21, 2025 (GLOBE NEWSWIRE) — Bitget, the world's largest Universal Exchange (UEX), today announced a strategic collaboration with Ampersan, an institutional liquidity provider serving both centralized and decentralized markets. The collaboration strengthens Bitget's institutional offering

Core AI Launches New AI-Powered Digital Marketing Business to Accelerate Global Growth

Core AI Launches New AI-Powered Digital Marketing Business to Accelerate Global Growth GlobeNewswire November 21, 2025 Miami, Nov. 21, 2025 (GLOBE NEWSWIRE) — Core AI Holdings, Inc. (Nasdaq: CHAI) (“Core AI” or the “Company“), an artificial intelligence infrastructure company building transformative and scalable offerings across multiple verticals, today announced the formation of Core Digital, a

Vera Bradley Announces Appointment of Ivan Brockman to Its Board of Directors

(NASDAQ:VRA), FORT WAYNE, Ind., Nov. 21, 2025 (GLOBE NEWSWIRE) — Vera Bradley, Inc. (“Vera Bradley” or the “Company”) (NASDAQ:VRA) today announced the appointment of Ivan Brockman to its Board of Directors effective November 17, 2025. “We are pleased to welcome Ivan to the Vera Bradley Board of Directors,” said Ian Bickley, Executive Chairman of the

Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease

(NASDAQ:SGMO), RICHMOND, Calif., Nov. 21, 2025 (GLOBE NEWSWIRE) — Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administration (FDA) has accepted Sangamo's request for a rolling submission and review of the Biologics License Application (BLA) for isaralgagene civaparvovec, or ST-920, a wholly owned investigational gene therapy

Clear Channel Outdoor Extends Partnership with Metropolitan Washington Airports Authority to Continue Digital Media Evolution at Washington Dulles International and Reagan National Airports

Clear Channel Continues Evolving DCA & IAD Advertising and Sponsorship Program to Integrate Seamlessly with Airport Architecture, Maximize Advertiser ROI and Enhance Passenger Journeys Clear Channel Outdoor'sAirports Division , the Americas-based airports business of Clear Channel Outdoor Holdings, Inc. (NYSE: CCO), today announced it was awarded, through a competitive process, a new 10-year contract (with

Shareholder Rights Advocates at Levi & Korsinsky Investigate Agios Pharmaceuticals, Inc. (AGIO) Regarding Possible Securities Fraud Violations

NEW YORK, NY / ACCESS Newswire / November 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Agios Pharmaceuticals, Inc. ("Agios Pharmaceuticals, Inc.") (NASDAQ:AGIO) concerning possible violations of federal securities laws. On November 19, 2025, Agios reported topline results from its RISE UP Phase 3 trial of Mitapivat in

Vera Bradley Announces Appointment of Ivan Brockman to Its Board of Directors

Vera Bradley Announces Appointment of Ivan Brockman to Its Board of Directors GlobeNewswire November 21, 2025 FORT WAYNE, Ind., Nov. 21, 2025 (GLOBE NEWSWIRE) — Vera Bradley, Inc. (“Vera Bradley” or the “Company”) (NASDAQ:VRA) today announced the appointment of Ivan Brockman to its Board of Directors effective November 17, 2025. “We are pleased to welcome

Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease

Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease GlobeNewswire November 21, 2025 RICHMOND, Calif., Nov. 21, 2025 (GLOBE NEWSWIRE) — Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administration (FDA) has accepted Sangamo's request for a rolling submission and

Scroll to Top